1198 related articles for article (PubMed ID: 7584144)
1. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
Tivol EA; Borriello F; Schweitzer AN; Lynch WP; Bluestone JA; Sharpe AH
Immunity; 1995 Nov; 3(5):541-7. PubMed ID: 7584144
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
3. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
Tivol EA; Boyd SD; McKeon S; Borriello F; Nickerson P; Strom TB; Sharpe AH
J Immunol; 1997 Jun; 158(11):5091-4. PubMed ID: 9164923
[TBL] [Abstract][Full Text] [Related]
4. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
Mandelbrot DA; McAdam AJ; Sharpe AH
J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625
[TBL] [Abstract][Full Text] [Related]
5. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
6. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
[TBL] [Abstract][Full Text] [Related]
7. The role of CTLA-4 in regulating Th2 differentiation.
Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
Chambers CA; Sullivan TJ; Allison JP
Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of CTLA-4 function in vivo.
Masteller EL; Chuang E; Mullen AC; Reiner SL; Thompson CB
J Immunol; 2000 May; 164(10):5319-27. PubMed ID: 10799894
[TBL] [Abstract][Full Text] [Related]
10. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
11. The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
Schweitzer AN; Sharpe AH
Agents Actions Suppl; 1998; 49():33-43. PubMed ID: 9426826
[TBL] [Abstract][Full Text] [Related]
12. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
15. B7-independent inhibition of T cells by CTLA-4.
Chikuma S; Abbas AK; Bluestone JA
J Immunol; 2005 Jul; 175(1):177-81. PubMed ID: 15972645
[TBL] [Abstract][Full Text] [Related]
16. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
Tivol EA; Gorski J
J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
Waterhouse P; Penninger JM; Timms E; Wakeham A; Shahinian A; Lee KP; Thompson CB; Griesser H; Mak TW
Science; 1995 Nov; 270(5238):985-8. PubMed ID: 7481803
[TBL] [Abstract][Full Text] [Related]
18. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
Frauwirth KA; Alegre ML; Thompson CB
J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.
Bachmann MF; Köhler G; Ecabert B; Mak TW; Kopf M
J Immunol; 1999 Aug; 163(3):1128-31. PubMed ID: 10415006
[TBL] [Abstract][Full Text] [Related]
20. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
